MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Najimi, M.
Right arrow Articles by Forgez, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Najimi, M.
Right arrow Articles by Forgez, P.

Vol. 62, Issue 3, 647-653, September 2002

Neurotensin Induces Tyrosine Hydroxylase Gene Activation through Nitric Oxide and Protein Kinase C Signaling Pathways

Mustapha Najimi,1 Jean-Jacques Robert, Jacques Mallet, William Rostène, and Patricia Forgez

Institut National de la Santé et de la Recherche Médicale U339, Hôpital Saint-Antoine, Paris, France (M.N., W.R., P.F.); and Centre National de la Recherche Scientifique Unité Mixte Recherche 9223, Hôpital de la Pitié-Salpétrière, Paris, France (J.J.R., J.M.)

The regulation of tyrosine hydroxylase (TH) represents an effective means to control the level of catecholamines, because TH is the major limiting enzyme of monoamine biosynthesis. The neuropeptide neurotensin (NT) is a neuromodulator of dopaminergic systems, and a direct interaction between NT and TH expression has been demonstrated in vivo and in vitro. In the present work, the molecular mechanisms and signaling pathways responsible for TH gene activation have been explored. In N1E-115 cells, NT agonist induced a TH protein level increase, correlating with a significant increase in TH mRNA abundance. This cellular response was the result of TH promoter activation, via c-fos and Jun D binding at the AP-1 responsive element. Using selective protein kinase C and nitric oxide synthase inhibitors, we demonstrate, by quantitative reverse transcription-polymerase chain reaction, gel shift, and protein assays, that TH gene activation by NT agonist requires both protein kinase C stimulation and nitric oxide production. The two pathways exert distinct roles; whereas nitric oxide synthase inhibitors blocked c-fos expression, protein kinase C inhibitors blocked that of Jun D. The requirement for two distinct and concomitant pathways by NT demonstrates a very fine level of control of specificity on TH gene activation.


1 Present address: Laboratoire de Pharmacologie Experimentale, Université Catholique de Louvain, 54.10 Avenue Hippocrate 54, 1200 Bruxelles, Belgique.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
M. A. Lopez-Toledano, C. Redondo, M. V.T. Lobo, D. Reimers, A. S. Herranz, C. L. Paino, and E. Bazan
Tyrosine Hydroxylase Induction by Basic Fibroblast Growth Factor and Cyclic AMP Analogs in Striatal Neural Stem Cells: Role of ERK1/ERK2 Mitogen-activated Protein Kinase and Protein Kinase C
J. Histochem. Cytochem., September 1, 2004; 52(9): 1177 - 1189.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics